Bio-Rad Laboratories, Inc. BIO.B Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $108.1M-34.4% | $164.9M+36.4% | $120.9M+3.8% | $116.5M-10.3% | $129.9M+4.6% | ||
| $30M-34.5% | $45.8M+44.5% | $31.7M-30.6% | $45.7M+32.8% | $34.4M-19.8% | ||
| $226.1M+62.9% | $138.8M-38.0% | $223.9M+46.1% | $153.2M-0.1% | $153.4M-31.2% | ||
| $145.1M-1.6% | $147.4M-26.5% | $200.6M-26.9% | $274.4M+60.3% | $171.2M-16.7% | ||
| $100K— | —— | —— | $100K— | $0— | ||
| -$93.2M-173% | -$34.2M+20.5% | -$43M+62.7% | -$115.4M-4,079% | $2.9M+110% | ||
| $47.8M— | $0-100% | $53.4M-61.9% | $140.2M+37.6% | $101.9M— | ||
| $100K-50.0% | $200K— | $0-100% | $200K+100% | $100K— | ||
| $3.4M-12.8% | $3.9M+14.7% | $3.4M-19.0% | $4.2M-2.3% | $4.3M+10.3% | ||
| -$44M— | $0+100% | -$52.5M+61.5% | -$136.3M-39.5% | -$97.7M-273% | ||
| $5.9M— | —— | —— | -$16.2M-800% | -$1.8M-118% | ||
| -$23.2M-117% | $134M+406% | $26.5M+118% | -$151.4M-555% | $33.3M-57.1% | ||
| $22.4M+1,936% | $1.1M-95.1% | $22.4M+2,389% | $900K-95.9% | $22.2M+2,367% | ||
| $11M+50.7% | $7.3M— | $0-100% | $48.2M+510% | $7.9M-66.7% | ||
| $515.8M-5.8% | $547.5M+5.8% | $517.5M+2.3% | $505.9M+3.7% | $488M-7.4% | ||
| -$9.9M— | —— | $8.6M-66.9% | $26M+213% | $8.3M— | ||
| $614.1M-12.0% | $697.7M+6.7% | $653.8M-1.7% | $664.9M+3.9% | $640M+1.2% | ||
| $33.3M+82.0% | $18.3M+32.6% | $13.8M-57.7% | $32.6M+100% | $16.3M-14.2% | ||
| —— | -$9.53M0.0% | -$9.53M0.0% | -$9.53M0.0% | -$9.53M-290% | ||
| $17.7M+490% | $3M-78.3% | $13.8M-46.3% | $25.7M+31.8% | $19.5M-34.6% | ||
| $145.1M-1.6% | $147.4M-26.5% | $200.6M-26.9% | $274.4M+60.3% | $171.2M-16.7% | ||
| $100K— | —— | —— | $100K— | $0— | ||
| $500K— | —— | —— | —— | $0— | ||
| —— | $3.95M0.0% | $3.95M0.0% | $3.95M0.0% | $3.95M-17.7% | ||
| —— | -$4.23M0.0% | -$4.23M0.0% | -$4.23M0.0% | -$4.23M-284% | ||
| —— | $11.65M0.0% | $11.65M0.0% | $11.65M0.0% | $11.65M+0.2% | ||
| $11M+50.7% | $7.3M— | $0-100% | $48.2M+510% | $7.9M-66.7% | ||
| $78.1M-34.4% | $119.1M+33.5% | $89.2M+26.0% | $70.8M-25.9% | $95.5M+17.5% | ||
| $78.1M-34.4% | $119.1M+33.5% | $89.2M+26.0% | $70.8M-25.9% | $95.5M+17.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Rad Laboratories, Inc. generate?
- Bio-Rad Laboratories, Inc. (BIO.B) generated $510.4M in operating cash flow over the trailing twelve months.
- What is Bio-Rad Laboratories, Inc.'s free cash flow?
- After $153.2M of capital expenditures, Bio-Rad Laboratories, Inc.'s free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
- Where does Bio-Rad Laboratories, Inc.'s cash flow data come from?
- Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
